Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Friday, September 11, 2020
The companies will work together on the advancement and commercial scale-up of Evonetix’s proprietary MEMS-based silicon chips and accelerate the development of Evonetix’s first product, a DNA desktop writer.
read more
Friday, September 11, 2020
REGENXBIO has dosed the first patient in its trial to evaluate the suprachoroidal delivery of RGX-314 using Clearside’s SCS Microinjector for the treatment of wet AMD.
read more
Friday, September 11, 2020
Direct Biologics will leverage Bioclinica's Interactive Response Technology (IRT) for their EXIT COVID-19 study.
read more
Friday, September 11, 2020
Catalent is investing $130 million to add five additional Phase 3 through commercial-scale manufacturing suites to its gene therapy campus in Maryland.
read more
Thursday, September 10, 2020
NKMax America has entered into a clinical trial collaboration and supply agreement with Merck KGaA, Darmstadt, Germany and Pfizer to evaluate the safety and tolerability of SNK01.
read more
Thursday, September 10, 2020
Sygnature Discovery has appointed Dr. Andy Mead as Director and Head of Drug Abuse and Substance Use Disorders at its integrated in vivo pharmacology company, RenaSci.
read more
Thursday, September 10, 2020
Exelixis and Catalent announced a partnership under which Catalent’s Redwood Bioscience subsidiary will develop multiple ADCs for Exelixis using Catalent’s proprietary SMARTag site-specific bioconjugation technology.
read more
Thursday, September 10, 2020
Presage Biosciences announced a new research collaboration with Takeda that will utilize CIVO to evaluate multiple investigational oncology agents and combinations in Phase 0 trials.
read more
Wednesday, September 09, 2020
PhoreMost and XtalPi have entered into a drug discovery collaboration agreement. Financial details are not disclosed.
read more
Wednesday, September 09, 2020
Catalent’s Redwood Bioscience subsidiary will develop multiple antibody-drug conjugates for Exelixis using Catalent’s proprietary SMARTag site-specific bioconjugation technology.
read more
Wednesday, September 09, 2020
Metrion Biosciences Limited has enhanced its global business development capabilities, with additional resources now committed to support key regions in the USA, Europe and Japan.
read more
Wednesday, September 09, 2020
Intravacc has been awarded a contract with base and options that may total US$9.4 million from the NIAID for the development of a prophylactic vaccine against enterovirus D68.
read more
Wednesday, September 09, 2020
APIS Assay Technologies has announced the acquisition of Beogenomics, a specialized software developer with proficiency in Bioinformatics and Artificial Intelligence (BIOX).
read more
Wednesday, September 09, 2020
Brickell has the right to develop AnGes’ proprietary investigational adjuvanted plasmid DNA vaccine intended to prevent COVID-19.
read more
Tuesday, September 08, 2020
AMRI has signed a supply agreement with AstraZeneca to support the manufacture of AstraZeneca’s COVID-19 vaccine candidate AZD1222.
read more